CHE logo

CHE
Chemed Corp.

296
Mkt Cap
$5.2B
Volume
523,981.00
52W High
$623.61
52W Low
$376.18
PE Ratio
20.58
CHE Fundamentals
Price
$377.99
Prev Close
$384.83
Open
$383.97
50D MA
$435.41
Beta
0.33
Avg. Volume
221,227.53
EPS (Annual)
$18.34
P/B
5.29
Rev/Employee
$160,013.79
$6,267.10
Loading...
Loading...
News
all
press releases
Chemed (NYSE:CHE) Hits New 12-Month Low - Time to Sell?
Chemed (NYSE:CHE) Reaches New 52-Week Low - Here's What Happened...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
WBI Investments LLC Makes New $2.36 Million Investment in Chemed Corporation $CHE
WBI Investments LLC acquired a new position in shares of Chemed Corporation (NYSE:CHE - Free Report) during the third quarter, according to the company in its most recent filing with the Securities...
MarketBeat·4d ago
News Placeholder
Now Open: VITAS Healthcare Inpatient Hospice Care at Oak Manor
Now Open: VITAS Healthcare Inpatient Hospice Care at Oak Manor Now Open: VITAS Healthcare Inpatient Hospice Care at Oak Manor PR Newswire LARGO, Fla., March 16, 2026 LARGO, Fla., March 16, 2026...
PR Newswire·6d ago
News Placeholder
Chemed Corporation $CHE Stock Position Lowered by Algert Global LLC
Algert Global LLC decreased its position in Chemed Corporation (NYSE:CHE - Free Report) by 28.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities...
MarketBeat·7d ago
News Placeholder
Chemed Corporation (NYSE:CHE) Short Interest Down 20.0% in February
Chemed Corporation (NYSE:CHE - Get Free Report) was the target of a significant decrease in short interest during the month of February. As of February 27th, there was short interest totaling 459,863...
MarketBeat·7d ago
News Placeholder
Aristotle Capital Boston LLC Acquires 3,737 Shares of Chemed Corporation $CHE
Aristotle Capital Boston LLC raised its stake in shares of Chemed Corporation (NYSE:CHE - Free Report) by 6.2% in the third quarter, according to the company in its most recent 13F filing with the...
MarketBeat·8d ago
News Placeholder
Chemed (NYSE:CHE) CEO Kevin Mcnamara Sells 2,000 Shares of Stock
Chemed Corporation (NYSE:CHE - Get Free Report) CEO Kevin Mcnamara sold 2,000 shares of the stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $403.18, for a...
MarketBeat·8d ago
News Placeholder
Chemed (NYSE:CHE) CEO Sells $806,360.00 in Stock
Chemed Corporation (NYSE:CHE - Get Free Report) CEO Kevin Mcnamara sold 2,000 shares of the business's stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of...
MarketBeat·9d ago
News Placeholder
First Trust Advisors LP Grows Stock Position in Chemed Corporation $CHE
First Trust Advisors LP increased its stake in Chemed Corporation (NYSE:CHE - Free Report) by 16.7% in the third quarter, according to the company in its most recent 13F filing with the Securities...
MarketBeat·13d ago
News Placeholder
Gabelli Funds LLC Raises Position in Chemed Corporation $CHE
Gabelli Funds LLC grew its stake in Chemed Corporation (NYSE:CHE - Free Report) by 8.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The...
MarketBeat·15d ago
<
1
2
...
>

Latest CHE News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.